1 Study Coverage
    1.1 Opioids Agonist Drugs Product Introduction
    1.2 Market by Type
        1.2.1 Global Opioids Agonist Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Codeine
        1.2.3 Fentanyl
        1.2.4 Meperidine
        1.2.5 Methadone
        1.2.6 Morphine
        1.2.7 Hydrocodone
    1.3 Market by Application
        1.3.1 Global Opioids Agonist Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Pain Management
        1.3.3 Cough Treatment
        1.3.4 Diarrhea Treatment
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Opioids Agonist Drugs Sales Estimates and Forecasts 2017-2028
    2.2 Global Opioids Agonist Drugs Revenue Estimates and Forecasts 2017-2028
    2.3 Global Opioids Agonist Drugs Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Opioids Agonist Drugs Sales by Region
        2.4.1 Global Opioids Agonist Drugs Sales by Region (2017-2022)
        2.4.2 Global Sales Opioids Agonist Drugs by Region (2023-2028)
    2.5 Global Opioids Agonist Drugs Revenue by Region
        2.5.1 Global Opioids Agonist Drugs Revenue by Region (2017-2022)
        2.5.2 Global Opioids Agonist Drugs Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Opioids Agonist Drugs Sales by Manufacturers
        3.1.1 Global Top Opioids Agonist Drugs Manufacturers by Sales (2017-2022)
        3.1.2 Global Opioids Agonist Drugs Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Opioids Agonist Drugs in 2021
    3.2 Global Opioids Agonist Drugs Revenue by Manufacturers
        3.2.1 Global Opioids Agonist Drugs Revenue by Manufacturers (2017-2022)
        3.2.2 Global Opioids Agonist Drugs Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Opioids Agonist Drugs Revenue in 2021
    3.3 Global Opioids Agonist Drugs Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Opioids Agonist Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Opioids Agonist Drugs Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Opioids Agonist Drugs Sales by Type
        4.1.1 Global Opioids Agonist Drugs Historical Sales by Type (2017-2022)
        4.1.2 Global Opioids Agonist Drugs Forecasted Sales by Type (2023-2028)
        4.1.3 Global Opioids Agonist Drugs Sales Market Share by Type (2017-2028)
    4.2 Global Opioids Agonist Drugs Revenue by Type
        4.2.1 Global Opioids Agonist Drugs Historical Revenue by Type (2017-2022)
        4.2.2 Global Opioids Agonist Drugs Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Opioids Agonist Drugs Revenue Market Share by Type (2017-2028)
    4.3 Global Opioids Agonist Drugs Price by Type
        4.3.1 Global Opioids Agonist Drugs Price by Type (2017-2022)
        4.3.2 Global Opioids Agonist Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Opioids Agonist Drugs Sales by Application
        5.1.1 Global Opioids Agonist Drugs Historical Sales by Application (2017-2022)
        5.1.2 Global Opioids Agonist Drugs Forecasted Sales by Application (2023-2028)
        5.1.3 Global Opioids Agonist Drugs Sales Market Share by Application (2017-2028)
    5.2 Global Opioids Agonist Drugs Revenue by Application
        5.2.1 Global Opioids Agonist Drugs Historical Revenue by Application (2017-2022)
        5.2.2 Global Opioids Agonist Drugs Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Opioids Agonist Drugs Revenue Market Share by Application (2017-2028)
    5.3 Global Opioids Agonist Drugs Price by Application
        5.3.1 Global Opioids Agonist Drugs Price by Application (2017-2022)
        5.3.2 Global Opioids Agonist Drugs Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Opioids Agonist Drugs Market Size by Type
        6.1.1 North America Opioids Agonist Drugs Sales by Type (2017-2028)
        6.1.2 North America Opioids Agonist Drugs Revenue by Type (2017-2028)
    6.2 North America Opioids Agonist Drugs Market Size by Application
        6.2.1 North America Opioids Agonist Drugs Sales by Application (2017-2028)
        6.2.2 North America Opioids Agonist Drugs Revenue by Application (2017-2028)
    6.3 North America Opioids Agonist Drugs Market Size by Country
        6.3.1 North America Opioids Agonist Drugs Sales by Country (2017-2028)
        6.3.2 North America Opioids Agonist Drugs Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Opioids Agonist Drugs Market Size by Type
        7.1.1 Europe Opioids Agonist Drugs Sales by Type (2017-2028)
        7.1.2 Europe Opioids Agonist Drugs Revenue by Type (2017-2028)
    7.2 Europe Opioids Agonist Drugs Market Size by Application
        7.2.1 Europe Opioids Agonist Drugs Sales by Application (2017-2028)
        7.2.2 Europe Opioids Agonist Drugs Revenue by Application (2017-2028)
    7.3 Europe Opioids Agonist Drugs Market Size by Country
        7.3.1 Europe Opioids Agonist Drugs Sales by Country (2017-2028)
        7.3.2 Europe Opioids Agonist Drugs Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Opioids Agonist Drugs Market Size by Type
        8.1.1 Asia Pacific Opioids Agonist Drugs Sales by Type (2017-2028)
        8.1.2 Asia Pacific Opioids Agonist Drugs Revenue by Type (2017-2028)
    8.2 Asia Pacific Opioids Agonist Drugs Market Size by Application
        8.2.1 Asia Pacific Opioids Agonist Drugs Sales by Application (2017-2028)
        8.2.2 Asia Pacific Opioids Agonist Drugs Revenue by Application (2017-2028)
    8.3 Asia Pacific Opioids Agonist Drugs Market Size by Region
        8.3.1 Asia Pacific Opioids Agonist Drugs Sales by Region (2017-2028)
        8.3.2 Asia Pacific Opioids Agonist Drugs Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Opioids Agonist Drugs Market Size by Type
        9.1.1 Latin America Opioids Agonist Drugs Sales by Type (2017-2028)
        9.1.2 Latin America Opioids Agonist Drugs Revenue by Type (2017-2028)
    9.2 Latin America Opioids Agonist Drugs Market Size by Application
        9.2.1 Latin America Opioids Agonist Drugs Sales by Application (2017-2028)
        9.2.2 Latin America Opioids Agonist Drugs Revenue by Application (2017-2028)
    9.3 Latin America Opioids Agonist Drugs Market Size by Country
        9.3.1 Latin America Opioids Agonist Drugs Sales by Country (2017-2028)
        9.3.2 Latin America Opioids Agonist Drugs Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Opioids Agonist Drugs Market Size by Type
        10.1.1 Middle East and Africa Opioids Agonist Drugs Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Opioids Agonist Drugs Revenue by Type (2017-2028)
    10.2 Middle East and Africa Opioids Agonist Drugs Market Size by Application
        10.2.1 Middle East and Africa Opioids Agonist Drugs Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Opioids Agonist Drugs Revenue by Application (2017-2028)
    10.3 Middle East and Africa Opioids Agonist Drugs Market Size by Country
        10.3.1 Middle East and Africa Opioids Agonist Drugs Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Opioids Agonist Drugs Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Purdue Pharma
        11.1.1 Purdue Pharma Corporation Information
        11.1.2 Purdue Pharma Overview
        11.1.3 Purdue Pharma Opioids Agonist Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Purdue Pharma Opioids Agonist Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Purdue Pharma Recent Developments
    11.2 Titan pharmaceuticals
        11.2.1 Titan pharmaceuticals Corporation Information
        11.2.2 Titan pharmaceuticals Overview
        11.2.3 Titan pharmaceuticals Opioids Agonist Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Titan pharmaceuticals Opioids Agonist Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Titan pharmaceuticals Recent Developments
    11.3 Boehringer Ingelheim
        11.3.1 Boehringer Ingelheim Corporation Information
        11.3.2 Boehringer Ingelheim Overview
        11.3.3 Boehringer Ingelheim Opioids Agonist Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Boehringer Ingelheim Opioids Agonist Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Boehringer Ingelheim Recent Developments
    11.4 Janssen Pharmaceuticals, Inc
        11.4.1 Janssen Pharmaceuticals, Inc Corporation Information
        11.4.2 Janssen Pharmaceuticals, Inc Overview
        11.4.3 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Janssen Pharmaceuticals, Inc Recent Developments
    11.5 Sanofi
        11.5.1 Sanofi Corporation Information
        11.5.2 Sanofi Overview
        11.5.3 Sanofi Opioids Agonist Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Sanofi Opioids Agonist Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Sanofi Recent Developments
    11.6 Sun Pharmaceuticals
        11.6.1 Sun Pharmaceuticals Corporation Information
        11.6.2 Sun Pharmaceuticals Overview
        11.6.3 Sun Pharmaceuticals Opioids Agonist Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Sun Pharmaceuticals Opioids Agonist Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Sun Pharmaceuticals Recent Developments
    11.7 Mallinckrodt Pharmaceuticals
        11.7.1 Mallinckrodt Pharmaceuticals Corporation Information
        11.7.2 Mallinckrodt Pharmaceuticals Overview
        11.7.3 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Mallinckrodt Pharmaceuticals Recent Developments
    11.8 Egalet Corporation
        11.8.1 Egalet Corporation Corporation Information
        11.8.2 Egalet Corporation Overview
        11.8.3 Egalet Corporation Opioids Agonist Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Egalet Corporation Opioids Agonist Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Egalet Corporation Recent Developments
    11.9 Endo Pharmaceuticals Inc.
        11.9.1 Endo Pharmaceuticals Inc. Corporation Information
        11.9.2 Endo Pharmaceuticals Inc. Overview
        11.9.3 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Endo Pharmaceuticals Inc. Recent Developments
    11.10 Allergan, Plc
        11.10.1 Allergan, Plc Corporation Information
        11.10.2 Allergan, Plc Overview
        11.10.3 Allergan, Plc Opioids Agonist Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Allergan, Plc Opioids Agonist Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Allergan, Plc Recent Developments
    11.11 Pfizer Inc
        11.11.1 Pfizer Inc Corporation Information
        11.11.2 Pfizer Inc Overview
        11.11.3 Pfizer Inc Opioids Agonist Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Pfizer Inc Opioids Agonist Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Pfizer Inc Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Opioids Agonist Drugs Industry Chain Analysis
    12.2 Opioids Agonist Drugs Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Opioids Agonist Drugs Production Mode & Process
    12.4 Opioids Agonist Drugs Sales and Marketing
        12.4.1 Opioids Agonist Drugs Sales Channels
        12.4.2 Opioids Agonist Drugs Distributors
    12.5 Opioids Agonist Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Opioids Agonist Drugs Industry Trends
    13.2 Opioids Agonist Drugs Market Drivers
    13.3 Opioids Agonist Drugs Market Challenges
    13.4 Opioids Agonist Drugs Market Restraints
14 Key Findings in The Global Opioids Agonist Drugs Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Opioids Agonist Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Codeine
    Table 3. Major Manufacturers of Fentanyl
    Table 4. Major Manufacturers of Meperidine
    Table 5. Major Manufacturers of Methadone
    Table 6. Major Manufacturers of Morphine
    Table 7. Major Manufacturers of Hydrocodone
    Table 8. Global Opioids Agonist Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Opioids Agonist Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 10. Global Opioids Agonist Drugs Sales by Region (2017-2022) & (K Units)
    Table 11. Global Opioids Agonist Drugs Sales Market Share by Region (2017-2022)
    Table 12. Global Opioids Agonist Drugs Sales by Region (2023-2028) & (K Units)
    Table 13. Global Opioids Agonist Drugs Sales Market Share by Region (2023-2028)
    Table 14. Global Opioids Agonist Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 15. Global Opioids Agonist Drugs Revenue Market Share by Region (2017-2022)
    Table 16. Global Opioids Agonist Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 17. Global Opioids Agonist Drugs Revenue Market Share by Region (2023-2028)
    Table 18. Global Opioids Agonist Drugs Sales by Manufacturers (2017-2022) & (K Units)
    Table 19. Global Opioids Agonist Drugs Sales Share by Manufacturers (2017-2022)
    Table 20. Global Opioids Agonist Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 21. Global Opioids Agonist Drugs Revenue Share by Manufacturers (2017-2022)
    Table 22. Opioids Agonist Drugs Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 23. Global Opioids Agonist Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 24. Global Opioids Agonist Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioids Agonist Drugs as of 2021)
    Table 25. Opioids Agonist Drugs Manufacturing Base Distribution and Headquarters
    Table 26. Manufacturers Opioids Agonist Drugs Product Offered
    Table 27. Date of Manufacturers Enter into Opioids Agonist Drugs Market
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Opioids Agonist Drugs Sales by Type (2017-2022) & (K Units)
    Table 30. Global Opioids Agonist Drugs Sales by Type (2023-2028) & (K Units)
    Table 31. Global Opioids Agonist Drugs Sales Share by Type (2017-2022)
    Table 32. Global Opioids Agonist Drugs Sales Share by Type (2023-2028)
    Table 33. Global Opioids Agonist Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 34. Global Opioids Agonist Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 35. Global Opioids Agonist Drugs Revenue Share by Type (2017-2022)
    Table 36. Global Opioids Agonist Drugs Revenue Share by Type (2023-2028)
    Table 37. Opioids Agonist Drugs Price by Type (2017-2022) & (USD/Unit)
    Table 38. Global Opioids Agonist Drugs Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 39. Global Opioids Agonist Drugs Sales by Application (2017-2022) & (K Units)
    Table 40. Global Opioids Agonist Drugs Sales by Application (2023-2028) & (K Units)
    Table 41. Global Opioids Agonist Drugs Sales Share by Application (2017-2022)
    Table 42. Global Opioids Agonist Drugs Sales Share by Application (2023-2028)
    Table 43. Global Opioids Agonist Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 44. Global Opioids Agonist Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 45. Global Opioids Agonist Drugs Revenue Share by Application (2017-2022)
    Table 46. Global Opioids Agonist Drugs Revenue Share by Application (2023-2028)
    Table 47. Opioids Agonist Drugs Price by Application (2017-2022) & (USD/Unit)
    Table 48. Global Opioids Agonist Drugs Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 49. North America Opioids Agonist Drugs Sales by Type (2017-2022) & (K Units)
    Table 50. North America Opioids Agonist Drugs Sales by Type (2023-2028) & (K Units)
    Table 51. North America Opioids Agonist Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 52. North America Opioids Agonist Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 53. North America Opioids Agonist Drugs Sales by Application (2017-2022) & (K Units)
    Table 54. North America Opioids Agonist Drugs Sales by Application (2023-2028) & (K Units)
    Table 55. North America Opioids Agonist Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 56. North America Opioids Agonist Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 57. North America Opioids Agonist Drugs Sales by Country (2017-2022) & (K Units)
    Table 58. North America Opioids Agonist Drugs Sales by Country (2023-2028) & (K Units)
    Table 59. North America Opioids Agonist Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 60. North America Opioids Agonist Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 61. Europe Opioids Agonist Drugs Sales by Type (2017-2022) & (K Units)
    Table 62. Europe Opioids Agonist Drugs Sales by Type (2023-2028) & (K Units)
    Table 63. Europe Opioids Agonist Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 64. Europe Opioids Agonist Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 65. Europe Opioids Agonist Drugs Sales by Application (2017-2022) & (K Units)
    Table 66. Europe Opioids Agonist Drugs Sales by Application (2023-2028) & (K Units)
    Table 67. Europe Opioids Agonist Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 68. Europe Opioids Agonist Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 69. Europe Opioids Agonist Drugs Sales by Country (2017-2022) & (K Units)
    Table 70. Europe Opioids Agonist Drugs Sales by Country (2023-2028) & (K Units)
    Table 71. Europe Opioids Agonist Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 72. Europe Opioids Agonist Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Opioids Agonist Drugs Sales by Type (2017-2022) & (K Units)
    Table 74. Asia Pacific Opioids Agonist Drugs Sales by Type (2023-2028) & (K Units)
    Table 75. Asia Pacific Opioids Agonist Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Opioids Agonist Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Opioids Agonist Drugs Sales by Application (2017-2022) & (K Units)
    Table 78. Asia Pacific Opioids Agonist Drugs Sales by Application (2023-2028) & (K Units)
    Table 79. Asia Pacific Opioids Agonist Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Opioids Agonist Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 81. Asia Pacific Opioids Agonist Drugs Sales by Region (2017-2022) & (K Units)
    Table 82. Asia Pacific Opioids Agonist Drugs Sales by Region (2023-2028) & (K Units)
    Table 83. Asia Pacific Opioids Agonist Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 84. Asia Pacific Opioids Agonist Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 85. Latin America Opioids Agonist Drugs Sales by Type (2017-2022) & (K Units)
    Table 86. Latin America Opioids Agonist Drugs Sales by Type (2023-2028) & (K Units)
    Table 87. Latin America Opioids Agonist Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 88. Latin America Opioids Agonist Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 89. Latin America Opioids Agonist Drugs Sales by Application (2017-2022) & (K Units)
    Table 90. Latin America Opioids Agonist Drugs Sales by Application (2023-2028) & (K Units)
    Table 91. Latin America Opioids Agonist Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 92. Latin America Opioids Agonist Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 93. Latin America Opioids Agonist Drugs Sales by Country (2017-2022) & (K Units)
    Table 94. Latin America Opioids Agonist Drugs Sales by Country (2023-2028) & (K Units)
    Table 95. Latin America Opioids Agonist Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 96. Latin America Opioids Agonist Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Opioids Agonist Drugs Sales by Type (2017-2022) & (K Units)
    Table 98. Middle East and Africa Opioids Agonist Drugs Sales by Type (2023-2028) & (K Units)
    Table 99. Middle East and Africa Opioids Agonist Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Opioids Agonist Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Opioids Agonist Drugs Sales by Application (2017-2022) & (K Units)
    Table 102. Middle East and Africa Opioids Agonist Drugs Sales by Application (2023-2028) & (K Units)
    Table 103. Middle East and Africa Opioids Agonist Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Opioids Agonist Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 105. Middle East and Africa Opioids Agonist Drugs Sales by Country (2017-2022) & (K Units)
    Table 106. Middle East and Africa Opioids Agonist Drugs Sales by Country (2023-2028) & (K Units)
    Table 107. Middle East and Africa Opioids Agonist Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 108. Middle East and Africa Opioids Agonist Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 109. Purdue Pharma Corporation Information
    Table 110. Purdue Pharma Description and Major Businesses
    Table 111. Purdue Pharma Opioids Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 112. Purdue Pharma Opioids Agonist Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 113. Purdue Pharma Recent Developments
    Table 114. Titan pharmaceuticals Corporation Information
    Table 115. Titan pharmaceuticals Description and Major Businesses
    Table 116. Titan pharmaceuticals Opioids Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 117. Titan pharmaceuticals Opioids Agonist Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 118. Titan pharmaceuticals Recent Developments
    Table 119. Boehringer Ingelheim Corporation Information
    Table 120. Boehringer Ingelheim Description and Major Businesses
    Table 121. Boehringer Ingelheim Opioids Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 122. Boehringer Ingelheim Opioids Agonist Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 123. Boehringer Ingelheim Recent Developments
    Table 124. Janssen Pharmaceuticals, Inc Corporation Information
    Table 125. Janssen Pharmaceuticals, Inc Description and Major Businesses
    Table 126. Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 127. Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 128. Janssen Pharmaceuticals, Inc Recent Developments
    Table 129. Sanofi Corporation Information
    Table 130. Sanofi Description and Major Businesses
    Table 131. Sanofi Opioids Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 132. Sanofi Opioids Agonist Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 133. Sanofi Recent Developments
    Table 134. Sun Pharmaceuticals Corporation Information
    Table 135. Sun Pharmaceuticals Description and Major Businesses
    Table 136. Sun Pharmaceuticals Opioids Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 137. Sun Pharmaceuticals Opioids Agonist Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 138. Sun Pharmaceuticals Recent Developments
    Table 139. Mallinckrodt Pharmaceuticals Corporation Information
    Table 140. Mallinckrodt Pharmaceuticals Description and Major Businesses
    Table 141. Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 142. Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 143. Mallinckrodt Pharmaceuticals Recent Developments
    Table 144. Egalet Corporation Corporation Information
    Table 145. Egalet Corporation Description and Major Businesses
    Table 146. Egalet Corporation Opioids Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 147. Egalet Corporation Opioids Agonist Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 148. Egalet Corporation Recent Developments
    Table 149. Endo Pharmaceuticals Inc. Corporation Information
    Table 150. Endo Pharmaceuticals Inc. Description and Major Businesses
    Table 151. Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 152. Endo Pharmaceuticals Inc. Opioids Agonist Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 153. Endo Pharmaceuticals Inc. Recent Developments
    Table 154. Allergan, Plc Corporation Information
    Table 155. Allergan, Plc Description and Major Businesses
    Table 156. Allergan, Plc Opioids Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 157. Allergan, Plc Opioids Agonist Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 158. Allergan, Plc Recent Developments
    Table 159. Pfizer Inc Corporation Information
    Table 160. Pfizer Inc Description and Major Businesses
    Table 161. Pfizer Inc Opioids Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 162. Pfizer Inc Opioids Agonist Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 163. Pfizer Inc Recent Developments
    Table 164. Key Raw Materials Lists
    Table 165. Raw Materials Key Suppliers Lists
    Table 166. Opioids Agonist Drugs Distributors List
    Table 167. Opioids Agonist Drugs Customers List
    Table 168. Opioids Agonist Drugs Market Trends
    Table 169. Opioids Agonist Drugs Market Drivers
    Table 170. Opioids Agonist Drugs Market Challenges
    Table 171. Opioids Agonist Drugs Market Restraints
    Table 172. Research Programs/Design for This Report
    Table 173. Key Data Information from Secondary Sources
    Table 174. Key Data Information from Primary Sources
List of Figures
    Figure 1. Opioids Agonist Drugs Product Picture
    Figure 3. Global Opioids Agonist Drugs Market Share by Type in 2021 & 2028
    Figure 3. Codeine Product Picture
    Figure 4. Fentanyl Product Picture
    Figure 5. Meperidine Product Picture
    Figure 6. Methadone Product Picture
    Figure 7. Morphine Product Picture
    Figure 8. Hydrocodone Product Picture
    Figure 9. Global Opioids Agonist Drugs Market Share by Application in 2021 & 2028
    Figure 10. Pain Management
    Figure 11. Cough Treatment
    Figure 12. Diarrhea Treatment
    Figure 13. Opioids Agonist Drugs Report Years Considered
    Figure 14. Global Opioids Agonist Drugs Sales 2017-2028 (K Units)
    Figure 15. Global Opioids Agonist Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Opioids Agonist Drugs Revenue 2017-2028 (US$ Million)
    Figure 17. Global Opioids Agonist Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 18. Global Opioids Agonist Drugs Sales Market Share by Region (2017-2022)
    Figure 19. Global Opioids Agonist Drugs Sales Market Share by Region (2023-2028)
    Figure 20. North America Opioids Agonist Drugs Sales YoY (2017-2028) & (K Units)
    Figure 21. North America Opioids Agonist Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Opioids Agonist Drugs Sales YoY (2017-2028) & (K Units)
    Figure 23. Europe Opioids Agonist Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Asia-Pacific Opioids Agonist Drugs Sales YoY (2017-2028) & (K Units)
    Figure 25. Asia-Pacific Opioids Agonist Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Latin America Opioids Agonist Drugs Sales YoY (2017-2028) & (K Units)
    Figure 27. Latin America Opioids Agonist Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. Middle East & Africa Opioids Agonist Drugs Sales YoY (2017-2028) & (K Units)
    Figure 29. Middle East & Africa Opioids Agonist Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 30. The Opioids Agonist Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 31. The Top 5 and 10 Largest Manufacturers of Opioids Agonist Drugs in the World: Market Share by Opioids Agonist Drugs Revenue in 2021
    Figure 32. Global Opioids Agonist Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 33. Global Opioids Agonist Drugs Sales Market Share by Type (2017-2028)
    Figure 34. Global Opioids Agonist Drugs Revenue Market Share by Type (2017-2028)
    Figure 35. Global Opioids Agonist Drugs Sales Market Share by Application (2017-2028)
    Figure 36. Global Opioids Agonist Drugs Revenue Market Share by Application (2017-2028)
    Figure 37. North America Opioids Agonist Drugs Sales Market Share by Type (2017-2028)
    Figure 38. North America Opioids Agonist Drugs Revenue Market Share by Type (2017-2028)
    Figure 39. North America Opioids Agonist Drugs Sales Market Share by Application (2017-2028)
    Figure 40. North America Opioids Agonist Drugs Revenue Market Share by Application (2017-2028)
    Figure 41. North America Opioids Agonist Drugs Sales Share by Country (2017-2028)
    Figure 42. North America Opioids Agonist Drugs Revenue Share by Country (2017-2028)
    Figure 43. U.S. Opioids Agonist Drugs Revenue (2017-2028) & (US$ Million)
    Figure 44. Canada Opioids Agonist Drugs Revenue (2017-2028) & (US$ Million)
    Figure 45. Europe Opioids Agonist Drugs Sales Market Share by Type (2017-2028)
    Figure 46. Europe Opioids Agonist Drugs Revenue Market Share by Type (2017-2028)
    Figure 47. Europe Opioids Agonist Drugs Sales Market Share by Application (2017-2028)
    Figure 48. Europe Opioids Agonist Drugs Revenue Market Share by Application (2017-2028)
    Figure 49. Europe Opioids Agonist Drugs Sales Share by Country (2017-2028)
    Figure 50. Europe Opioids Agonist Drugs Revenue Share by Country (2017-2028)
    Figure 51. Germany Opioids Agonist Drugs Revenue (2017-2028) & (US$ Million)
    Figure 52. France Opioids Agonist Drugs Revenue (2017-2028) & (US$ Million)
    Figure 53. U.K. Opioids Agonist Drugs Revenue (2017-2028) & (US$ Million)
    Figure 54. Italy Opioids Agonist Drugs Revenue (2017-2028) & (US$ Million)
    Figure 55. Russia Opioids Agonist Drugs Revenue (2017-2028) & (US$ Million)
    Figure 56. Asia Pacific Opioids Agonist Drugs Sales Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Opioids Agonist Drugs Revenue Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Opioids Agonist Drugs Sales Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Opioids Agonist Drugs Revenue Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Opioids Agonist Drugs Sales Share by Region (2017-2028)
    Figure 61. Asia Pacific Opioids Agonist Drugs Revenue Share by Region (2017-2028)
    Figure 62. China Opioids Agonist Drugs Revenue (2017-2028) & (US$ Million)
    Figure 63. Japan Opioids Agonist Drugs Revenue (2017-2028) & (US$ Million)
    Figure 64. South Korea Opioids Agonist Drugs Revenue (2017-2028) & (US$ Million)
    Figure 65. India Opioids Agonist Drugs Revenue (2017-2028) & (US$ Million)
    Figure 66. Australia Opioids Agonist Drugs Revenue (2017-2028) & (US$ Million)
    Figure 67. Taiwan Opioids Agonist Drugs Revenue (2017-2028) & (US$ Million)
    Figure 68. Indonesia Opioids Agonist Drugs Revenue (2017-2028) & (US$ Million)
    Figure 69. Thailand Opioids Agonist Drugs Revenue (2017-2028) & (US$ Million)
    Figure 70. Malaysia Opioids Agonist Drugs Revenue (2017-2028) & (US$ Million)
    Figure 71. Philippines Opioids Agonist Drugs Revenue (2017-2028) & (US$ Million)
    Figure 72. Latin America Opioids Agonist Drugs Sales Market Share by Type (2017-2028)
    Figure 73. Latin America Opioids Agonist Drugs Revenue Market Share by Type (2017-2028)
    Figure 74. Latin America Opioids Agonist Drugs Sales Market Share by Application (2017-2028)
    Figure 75. Latin America Opioids Agonist Drugs Revenue Market Share by Application (2017-2028)
    Figure 76. Latin America Opioids Agonist Drugs Sales Share by Country (2017-2028)
    Figure 77. Latin America Opioids Agonist Drugs Revenue Share by Country (2017-2028)
    Figure 78. Mexico Opioids Agonist Drugs Revenue (2017-2028) & (US$ Million)
    Figure 79. Brazil Opioids Agonist Drugs Revenue (2017-2028) & (US$ Million)
    Figure 80. Argentina Opioids Agonist Drugs Revenue (2017-2028) & (US$ Million)
    Figure 81. Middle East and Africa Opioids Agonist Drugs Sales Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Opioids Agonist Drugs Revenue Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Opioids Agonist Drugs Sales Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Opioids Agonist Drugs Revenue Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa Opioids Agonist Drugs Sales Share by Country (2017-2028)
    Figure 86. Middle East and Africa Opioids Agonist Drugs Revenue Share by Country (2017-2028)
    Figure 87. Turkey Opioids Agonist Drugs Revenue (2017-2028) & (US$ Million)
    Figure 88. Saudi Arabia Opioids Agonist Drugs Revenue (2017-2028) & (US$ Million)
    Figure 89. U.A.E Opioids Agonist Drugs Revenue (2017-2028) & (US$ Million)
    Figure 90. Opioids Agonist Drugs Value Chain
    Figure 91. Opioids Agonist Drugs Production Process
    Figure 92. Channels of Distribution
    Figure 93. Distributors Profiles
    Figure 94. Bottom-up and Top-down Approaches for This Report
    Figure 95. Data Triangulation
    Figure 96. Key Executives Interviewed